Elevance Health Short-Term Borrowings increased by 382.7% to $724.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 189.6%, from $250.00M to $724.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $175.00M | $175.00M | $275.00M | $275.00M | $175.00M | $265.00M | $265.00M | $265.00M | $265.00M | $0.00 | $225.00M | $1.58B | $225.00M | $360.00M | $365.00M | $250.00M | $360.00M | $180.00M | $150.00M | $724.00M |
| QoQ Change | — | +0.0% | +57.1% | +0.0% | -36.4% | +51.4% | +0.0% | +0.0% | +0.0% | -100.0% | — | +600.0% | -85.7% | +60.0% | +1.4% | -31.5% | +44.0% | -50.0% | -16.7% | +382.7% |
| YoY Change | — | — | — | — | +0.0% | +51.4% | -3.6% | -3.6% | +51.4% | -100.0% | -15.1% | +494.3% | -15.1% | — | +62.2% | -84.1% | +60.0% | -50.0% | -58.9% | +189.6% |